{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:05:55Z","timestamp":1791378355529,"version":"4.3.2"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12328-026-02353-w","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:17:18Z","timestamp":1784089038000},"page":"1029-1035","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HER2-positive rectal adenocarcinoma metastatic to the pancreas complicated by obstructive pancreatitis and an infected pseudocyst: a case report"],"prefix":"10.1007","volume":"19","author":[{"given":"Hiroumi","family":"Akita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Yamaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayoko","family":"Tayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Yoshinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2473-6966","authenticated-orcid":false,"given":"Yasuhito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"2353_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2025.105869","volume":"161","author":"M Cui","year":"2025","unstructured":"Cui M, Amed M, Reid MD, et al. Secondary pancreatic tumors in endoscopic ultrasound-guided fine-needle biopsy: Clinicopathologic characteristics and morphological diagnostic challenges. Hum Pathol. 2025;161:105869.","journal-title":"Hum Pathol"},{"key":"2353_CR2","first-page":"1","volume":"42","author":"S Ahcene Djaballah","year":"2022","unstructured":"Ahcene Djaballah S, Daniel F, Milani A, et al. HER2 in colorectal cancer: The long and winding road from negative predictive factor to positive actionable target. Am Soc Clin Oncol Educ Book. 2022;42:1\u201314.","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2353_CR3","doi-asserted-by":"crossref","unstructured":"Benson AB, Venook AP, Al-Hawary MM, et al. Colon Cancer, version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021;19:329\u2013359.","DOI":"10.6004\/jnccn.2021.0012"},{"key":"2353_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","volume":"34","author":"A Cervantes","year":"2023","unstructured":"Cervantes A, Adam R, Rosell\u00f3 S, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up\u2606. Ann Oncol. 2023;34:10\u201332.","journal-title":"Ann Oncol"},{"key":"2353_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1200\/JCO.23.02005","volume":"42","author":"F Meric-Bernstam","year":"2024","unstructured":"Meric-Bernstam F, Makker V, Oaknin A, et al. Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors: Primary results from the DESTINY-PanTumor02 phase II trial. J Clin Oncol. 2024;42:47\u201358.","journal-title":"J Clin Oncol"},{"key":"2353_CR6","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.3748\/wjg.v17.i43.4747","volume":"17","author":"R Ballarin","year":"2011","unstructured":"Ballarin R, Spaggiari M, Cautero N, et al. Pancreatic metastases from renal cell carcinoma: the state of the art. World J Gastroenterol. 2011;17:4747\u201356.","journal-title":"World J Gastroenterol"},{"key":"2353_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ejso.2013.12.022","volume":"40","author":"H Adler","year":"2014","unstructured":"Adler H, Redmond CE, Heneghan HM, et al. Pancreatectomy for metastatic disease: a systematic review. Eur J Surg Oncol. 2014;40:379\u201386.","journal-title":"Eur J Surg Oncol"},{"key":"2353_CR8","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s00261-012-9856-8","volume":"38","author":"S Ahmed","year":"2013","unstructured":"Ahmed S, Johnson PT, Hruban R, Fishman EK. Metastatic disease to the pancreas: pathologic spectrum and CT patterns. Abdom Imaging. 2013;38:144\u201353.","journal-title":"Abdom Imaging"},{"key":"2353_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000913","volume":"94","author":"HY Shi","year":"2015","unstructured":"Shi HY, Zhao XS, Miao F. Metastases to the pancreas: Computed tomography imaging spectrum and clinical features: A retrospective study of 18 patients with 36 metastases. Medicine (Baltimore). 2015;94:e913.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"2353_CR10","first-page":"45","volume":"16","author":"I Tsitouridis","year":"2010","unstructured":"Tsitouridis I, Diamantopoulou A, Michaelides M, Arvanity M, et al. Pancreatic metastases: CT and MRI findings. Diagn Interv Radiol. 2010;16(1):45\u201351.","journal-title":"Diagn Interv Radiol"},{"key":"2353_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.clinimag.2018.01.016","volume":"51","author":"M Galia","year":"2018","unstructured":"Galia M, Albano D, Picone D, et al. Imaging features of pancreatic metastases: A comparison with pancreatic ductal adenocarcinoma. Clin Imaging. 2018;51:76\u201382.","journal-title":"Clin Imaging"},{"key":"2353_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00535-018-1519-2","volume":"54","author":"M Kitano","year":"2019","unstructured":"Kitano M, Yoshida T, Itonaga M, et al. Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer. J Gastroenterol. 2019;54:19\u201332.","journal-title":"J Gastroenterol"},{"key":"2353_CR13","volume":"16","author":"MS Elnady","year":"2022","unstructured":"Elnady MS, Eltatawy FA, Nosseir AG, et al. Diagnostic accuracy of SATB2 in identifying primary and metastatic colorectal carcinoma: a comparative immunohistochemical study. Ecancermedsci. 2022;16:1491.","journal-title":"Ecancermedsci"},{"key":"2353_CR14","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S1470-2045(16)00150-9","volume":"17","author":"A Sartore-Bianchi","year":"2016","unstructured":"Sartore-Bianchi A, Trusolino L, Martino C, et al. Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12\/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial. Lancet Oncol. 2016;17:738\u201346.","journal-title":"Lancet Oncol"},{"key":"2353_CR15","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S1470-2045(18)30904-5","volume":"20","author":"F Meric-Bernstam","year":"2019","unstructured":"Meric-Bernstam F, Hurwitz H. Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study. Lancet Oncol. 2019;20:518\u201330.","journal-title":"Lancet Oncol"},{"key":"2353_CR16","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1038\/s41591-021-01553-w","volume":"27","author":"Y Nakamura","year":"2021","unstructured":"Nakamura Y, Okamoto W, Kato T, et al. Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial. Nat Med. 2021;27:1899\u2013903.","journal-title":"Nat Med"},{"key":"2353_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.70352\/scrj.cr.25-0304","volume":"11","author":"R Tanida","year":"2025","unstructured":"Tanida R, Tanaka T, Hamada-Nishimoto M, et al. Trastuzumab deruxtecan significantly reduces human epidermal growth factor receptor 2-positive pancreatic metastasis from advanced breast cancer: A case report. Surg Case Rep. 2025;11:25\u20130304.","journal-title":"Surg Case Rep"},{"key":"2353_CR18","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s00534-013-0598-y","volume":"20","author":"Y Minato","year":"2013","unstructured":"Minato Y, Kamisawa T, Tabata T, et al. Pancreatic cancer causing acute pancreatitis: a comparative study with cancer patients without pancreatitis and pancreatitis patients without cancer. J Hepatobiliary Pancreat Sci. 2013;20:628\u201333.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2353_CR19","doi-asserted-by":"publisher","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","volume":"27","author":"J Klastersky","year":"2016","unstructured":"Klastersky J, de Naurois J, Rolston K, et al. Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. Ann Oncol. 2016;27:v111\u20138.","journal-title":"Ann Oncol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02353-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-026-02353-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02353-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:43:11Z","timestamp":1791376991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-026-02353-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2353"],"URL":"https:\/\/doi.org\/10.1007\/s12328-026-02353-w","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The corresponding author, Yasuhito Tanaka, has received lecture fees from Chugai Pharmaceutical Co., Ltd. The other authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","label":"Human rights","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}